Литература
- Russo P. M., Fino E., Mancini C., Mazzetti M. Hr QoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. J. Eur. Acad. Dermatol. Venereol. 2019, № 33: 608–611.
- Inui S., Itami S. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011, № 61(1): 1-6.
- Liu Y., Liu Y., Zhao J., Deng T., et al. Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment. Front Bioeng Biotechnol. 2025, № 13: 1614090.
- Nestor M. S., Ablon G., Gade A., Han H., Fischer D. L. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021, № 12: 3759-3781.
- Pan R., Zhang G., Deng F. Effects of red light on sleep and mood in healthy subjects and individuals with insomnia disorder. Front. Psychiatry. 2023.
- Lee S. H., Kim K. W., Min K. M., Kim K. W., et al. Angiogenin reduces immune inflammation via inhibition of TANK-binding kinase 1 expression inhuman corneal fibroblast cells. Mediators Inflamm. 2014.
- Li W., Man X.-Y., Li C.-M. EGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK. Experimental Cell Research. 2012, № 318(14): 1633-40.